Definiens Immunoprofiling Panel

Mar 09, 2016

Definiens has launched its Immunoprofiling panel, which allows researchers to rapidly screen tissue samples for immune responses. The panel uses biomarkers within tumors to measure immune response. Currently, the panel includes biomarkers PD-1, PD-L1, OX40, CTLA-4, CD3, CD4, CD8, CD20, CD68, CD163, and FoxP3.

Breaking News

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.

Definiens Immunoprofiling Panel

Fetal Hemoglobin Gene Regulation Study Points to Potential Therapeutic Targets

Fulgent Genetics Q1 Revenues Soar on SARS-CoV-2 Testing

Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent

Quidel Q1 Revenues More Than Double but Miss Expectations

Twist Bioscience Q2 Revenues Grow 62 Percent

Natera Q1 Revenues Grow 62 Percent

US Supports Patent Waivers

Vaccines Versus Variants

CRISPR for What Ails You

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants